Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X Rex Heuermann, the Long Island architect and family man accused of being the Gilgo Beach serial ...
In the world of open source software, licenses stipulate the conditions for reusing and modifying source code, but AI could make it easier to reimplement open source code, potentially circumventing ...
Computer engineers and programmers have long relied on reverse engineering as a way to copy the functionality of a computer program without copying that program’s copyright-protected code directly.
LONDON, March 09, 2026 (GLOBE NEWSWIRE) -- Smarkets, one of the UK's leading prediction markets, has filed for a license with the U.S. Commodity Futures Trading Commission (CFTC), marking its formal ...
TO ADDRESS THIS. YES, THAT’S RIGHT, A BILL UNDER CONSIDERATION WILL HELP GRADS OF NONPROFIT TRAINING CENTERS LIKE THIS ONE. IT REMOVES THE PROVISIONAL LICENSE WAITING PERIOD FOR ADULTS WITHOUT ...
UCB and Antengene enter global license agreement for ATG-201, a B cell-depleting bispecific antibody
UCB obtains worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody, targeting B cell-related autoimmune diseases Deal ...
UCB secured worldwide exclusive rights to develop, manufacture, and commercialize ATG-201, including access to Antengene’s enabling manufacturing technology for this bispecific T-cell engager modality ...
This page may contain affiliate links to legal sports betting partners. If you sign up or place a wager, FOX Sports may be compensated. Read more about Sports Betting on FOX Sports. It’s a loaded NBA ...
HONG KONG and BRUSSELS, March 3, 2026 /PRNewswire/ -- Antengene Corporation Limited (Antengene), a leading innovative, commercial-stage global biotech company, and UCB, a global biopharmaceutical ...
Antengene grants UCB worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody, targeting B cell-related autoimmune diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results